SAMHSA Course June 9 on Treating Pregnant Women with Opioid Disorders
The Substance Abuse and Mental Health Services Administration will offer a free course June 9 in Philadelphia for physicians and other health care professionals who care for pregnant women with opioid use disorder and substance-exposed infants. Based on SAMHSA guidance, the course is designed to help health care professionals make clinically appropriate and individualized treatment decisions that promote the best possible outcome for both mother and infant. For more information and to register, click here.
Related News Articles
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…